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Selective medical treatment of infected aneurysms
of the aorta in high risk patients
Ron-Bin Hsu, MD, Chung-I Chang, MD, I-Hui Wu, MD, and Fang-Yue Lin, MD, Taiwan, Republic of China
Background: Infected aneurysm of the aorta is almost always fatal without undergoing aortic resection.Medical treatment
was attempted selectively in patients who were considered too high risk for surgery. We review our experience with 22
patients treated without undergoing aortic resection over 12 years.
Methods: Retrospective chart review.
Results:Between 1995 and 2007, 22 cases of infected aortic aneurysms treatedwithout undergoing aortic resection during the
first admission were included. There were 17 men with a median age of 76 years (range, 35 to 88 years). Of 18 pathogens
isolated, the most common responsible microorganism was nontyphoid Salmonella in 11 followed by Staphylococcus aureus in
five. The site of infection was thoracic in eight and abdominal in 14. The hospital mortality rate was 50%, and the
aneurysm-related mortality rate after long-term follow-up was 59%. The event-free survival rate at one year was 32%. Of 11
patients with Salmonella infection, eight patients have lived beyond 30 days and six were event-free after one year. Of 11
patients with non-Salmonella, four patients have lived beyond 30 days and only one was event-free after one year. The overall
aneurysm-related mortality rate was 36% in Salmonella infected patients and 82% in non-Salmonella infected patients.
Conclusion: Clinical results of medical treatment using current antibiotics in patients with infected aortic aneurysm were
poor. Traditional surgical excision of infected aortic aneurysms with revascularization remains the gold standard and
should be attempted except in high risk patients. ( J Vasc Surg 2009;49:66-70.)An infected aneurysm of the aorta and adjacent arteries
is a rare but life-threatening condition.1-7 Early diagnosis,
more potent antibiotics, and timely surgical intervention
have resulted in improved outcome over the last two de-
cades.1-7 The hospital mortality rates of combined medical
and surgical treatment ranged from 16% to 44%.1-7 The
clinical outcome is especially poor in patients with infection
caused by nontyphoid Salmonella.8-11 There were almost
no hospital survivors if such patients were treated medically
without undergoing aortic resection.11-13 Infected aortic
aneurysm is common in Taiwan and Hong Kong.14-19 We
have reported that death from rupture in patients treated
medically without undergoing aortic resection is likely but
not inevitable.17 However, only 11 cases were reported
then. Here, we review our experience in 22 patients treated
without undergoing aortic resection over 12 years. This
current report includes the previously reported 11cases.
PATIENTS AND METHODS
Setting. National Taiwan University Hospital (Taipei,
Taiwan) is a 2200-bed tertiary care hospital. It serves an
urban population of two million persons as both a first-line
and tertiary care facility. It serves also as a referral center for
other hospitals in the country with a population of 22
million persons.
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66Patients. The study patients were obtained from a
retrospective analysis of the clinical data for patients with
infected aneurysms of the aorta from September 1995 to
September 2007. Patients treated without undergoing aor-
tic resection during the first admission were included in this
study. In the same time period, 64 patients were treated
conventionally with surgical resection as well as antibiotics.
Diagnosis. Clinically, an infected aortic aneurysm was
usually preceded by infected aorta or aortitis. Infected aorta
was diagnosed with clinical evidence of infection (fever and
leukocytosis) and periaortic soft tissue infiltration demon-
strated by imaging study with either computed tomogra-
phy or magnetic resonance imaging.20 Blood culture was
used to define the responsible micro-organism.
Medical treatment. As described previously,16,17 in-
travenous antibiotic was given once the diagnosed was
confirmed. For patients with Salmonella species infections,
intravenous ceftriaxone (1000-2000 gm every 12 hours)
was used. For patients with non-salmonella infections, an-
tibiotic was based on culture result and sensitivity test.
Antibiotics were administered intravenously in the hospital
for at least six to eight weeks and until the clinical and labora-
tory parameters (fever, white cell count, and C-reactive pro-
tein) were normalized. Antibiotic was continued orally
after discharge. Imaging studies were repeated three to
six months after discharge.
Data collection. Data on age, sex,medical co-morbidities,
location of infected aneurysms, and clinical outcome
were collected retrospectively from the medical records.
Aneurysm-relatedmortality was defined as mortality caused
by persistent infection, aneurysm rupture, or unexplained
death within one year after the diagnosis of infected aneu-
rysm. The event-free survival was defined as patients who
survived and were free from aneurysm-related operations.
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Patient characteristics. From 1995 to 2007, 22 pa-
tients with infected aortic aneurysms were treated without
undergoing aortic resection during the first hospital admis-
sion. Patient demographics are shown in Table I. There
were 17 men and five women with median age of 76 years
(range, 35 to 88 years). The medical co-morbidities in-
cluded hypertension in eight patients, diabetes mellitus in
seven, coronary artery disease in three, end-stage renal
disease with regular hemodialysis in four, liver cirrhosis in
four, malignancy in two, and chronic obstructive pulmo-
nary disease, pulmonary tuberculosis, human immunodefi-
ciency virus infection, infective endocarditis, and rheuma-
toid arthritis in one each.
Of the 22 patients, 19 patients were febrile at presen-
tation and 10 patients had localized chest or back pain.
None was in shock at the time of presentation. Hemoptysis
was present in one patient with an infected aneurysmwithin
the thoracic cavity, and a consciousness disturbance was
present in two patients. The initial imaging findings were
aortic pseudoaneurysm or saccular aneurysm in 20 patients,
fusiform aneurysm in one, and infected aortitis in one. The
size of pseudoaneurysm ranged from 2.2 to 12 cm in
maximal diameter. The site of infection was the aortic arch
in four patients, the descending thoracic aorta in four, the
suprarenal abdominal aorta in six, the infrarenal abdominal
aorta in six, and the iliac artery in two (Tables I and II).
Microbiology. All but four patients had a positive
blood culture. Of the 18 isolates, the 11 most common
responsible microorganism was nontyphoid Salmonella in
Table I. Patient data of infected aneurysm of the thoracic
No. Gender
Age in
years Pathogen Imaging finding
1 M 88 Salmonella,
typhimurium
Descending thoracic aorta
pseudoaneurysm 4.5 cm
7 M 70 Salmonella
choleraesuis
Distal aortic arch, infected
aorta
8 M 80 Mycobacterium
tuberculosis
Descending thoracic aorta
pseudoaneurysm 6 cm
9 M 49 Salmonella
choleraesuis
Distal aortic arch,
pseudoaneurysm 5 cm
15 M 83 Staphylococcus
aureus
Descending thoracic aorta
pseudoaneurysm 5 cm
21 M 82 Unknown Distal aortic arch,
pseudoaneurysm 2.3 cm
22 M 75 Unknown Descending thoracic aorta
pseudoaneurysm 4.4 cm
23 F 84 Staphylococcus
aureus
Distal aortic arch,
pseudoaneurysm 4.1 cm
GI, gastrointestinal bleeding.11 patients (61%), followed by Staphylococcus aureus in five(28%), Escherichia coli in one, and Mycobacterium tubercu-
losis in one. The serotypes of isolated nontyphoid Salmo-
nellas were Salmonella cholerasuis in five patients, Salmo-
nella enteritidis in five, Salmonella typhimurium in two,
and unknown serotype in one (Tables I and II). All isolates
of nontyphoid Salmonella were sensitive to ceftriaxone and
ciprofloxacin.
Management. Once the diagnosis was confirmed, open
surgical repair was advised in all patients. However, operation
was refused by the patients because of old age in 10 patients,
severe medical co-morbidities in 13, or simply patient’s pref-
erence in three (Tables I and II). Furthermore, most of these
patients were deemed to be unlikely to survive resection
surgery and to be at risk for a high rate of postoperative
complications because of old age and medical co-morbidity.
Aneurysm location and clinical outcome were summa-
rized in the Fig. There were eight patients with infection
within the thoracic cavity: the aortic arch in four patients
and the descending thoracic aorta in four (Table I). Of the
four patients with infected aortic arch aneurysms, two
patients died of aneurysm rupture. There was one late death
after 22months because of an advanced bladder carcinoma.
Of the four patients with infected descending thoracic
aortic aneurysms, three patients died of aneurysm rupture,
and one patient died suddenly at home. There were 14
patients with aortic infection within the abdominal cavity;
six infections of the suprarenal abdominal aorta, six of the
infrarenal abdominal aorta, and two of an iliac artery (Table
II). Of the six patients with infected suprarenal abdominal
aortic aneurysms, two patients died of aneurysm rupture.
a treated without aortic resection
e of antibiotic
Reason for no
operation Hospital outcome Late outcome
triaxone Old age Died after 5 days,
aneurysm
rupture
rofloxacin Co-morbidity Alive Died after 22
months,
bladder
carcinoma
niazid,
thambutol,
lus rifampin
Old age Alive Died after 2
months,
sudden
death
triaxone then
iprofloxacin
Co-morbidity Alive Alive after 80
months
acillin Old age, co-
morbidity
Died after 11 days,
aneurysm
rupture
triaxone Old age, co-
morbidity
Died after 1 day,
GI bleeding
triaxone Co-morbidity Died after 19 days,
aneurysm
rupture
comycin Old age, co-
morbidity
Died after 44 days,
sepsisaort
Typ
, Cef
Cip
, Iso
e
p
Cef
c
, Ox
Cef
, Cef
VanOne patient with systemic lupus erythematosus and throm-
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grafting after eight years because of aneurysm rupture. One
patient underwent a successful aortic grafting after six
months because of aneurysm expansion. There were two
late deaths. Of the six patients with infected infrarenal
abdominal aortic aneurysms, four patients died of aneurysm
Table II. Patient data of infected aneurysm of the abdom
No. Gender
Age in
years Pathogen Imaging finding Typ
2 M 77 Staphylococcus
aureus
Infrarenal abdominal
aorta,
pseudoaneurysm
3 cm
Tic
c
p
3 M 69 Unknown Infrarenal abdominal
aorta, fusiform
aneurysm 8 cm
Cef
4 F 35 Salmonella
choleraesuis
Suprarenal abdominal
aorta,
pseudoaneurysm
4.5 cm
Cef
c
5 F 82 Escherichia coli Infrarenal abdominal
aorta,
pseudoaneurysm
4 cm
Cef
6 F 55 Salmonella Infrarenal abdominal
aorta,
pseudoaneurysm
3 cm
Cef
c
10 M 83 Salmonella
choleraesuis
Infrarenal abdominal
aorta,
pseudoaneurysm
4 cm
Cef
11 M 86 Salmonella
enteritidis
Suprarenal abdominal
aorta,
pseudoaneurysm
5.5 cm
Cef
12 M 88 Staphylococcus
aureus
Suprarenal abdominal
aorta,
pseudoaneurysm
6 cm
Tei
fl
14 M 76 Salmonella,
typhimurium
Suprarenal abdominal
aorta,
pseudoaneurysm
4 cm
Cef
c
16 M 75 Salmonella
choleraesuis
Iliac artery,
pseudoaneurysm
2.2 cm
Cef
c
17 M 59 Salmonella
enteritidis
Suprarenal abdominal
aorta,
pseudoaneurysm
5.6 cm
Cef
C
t
18 M 83 Unknown Suprarenal abdominal
aorta,
pseudoaneurysm
3 cm
Cef
c
19 M 38 Salmonella
enteritidis
Iliac artery,
pseudoaneurysm
12 cm
Cef
c
20 F 55 Staphylococcus
aureus
Infrarenal abdominal
aorta,
pseudoaneurysm
2 cm
Van
GI, gastrointestinal bleeding.rupture. Of the two patients with infected iliac artery aneu-rysms, one patient with human immunodeficiency virus
infection died after eight months of aneurysm rupture and
massive gastrointestinal bleeding.
Overall, in the 22 patients treated medically without
undergoing aortic resection, the in-hospital mortality rate
was 50% (11 of 22), and the aneurysm-related mortality
orta and adjacent arteries treated without aortic resection
ntibiotic
Reason for no
operation Hospital outcome Late outcome
n with
nic acid
ikacin
Co-morbidity Died after 1 day
aneurysm
rupture
ne Patient
preference
Alive Died after 15 days,
aneurysm
rupture
ne then
oxacin
Co-morbidity Alive Aneurysm rupture
and grafting
after 8 years
n Old age, co-
morbidity
Died after 4 days,
aneurysm
rupture
ne then
oxacin
Patient
preference
Alive Alive after 8 years
ne Old age Died after 17 days,
aneurysm
rupture
ne Old age Died after 11 days,
aneurysm
rupture
nin plus
xef
Old age Died after 40 days,
aneurysm
rupture
me then
oxacin
Co-morbidity Alive Died after 21
months, heart
failure
ne then
oxacin
Co-morbidity Alive Alive after 35
months
ne then
azole
Patient
preference
Alive Aneurysm
expansion and
grafting after 6
months
ne then
oxacin
Old age Alive Died after 17
months, organ
failure
ne then
oxacin
Co-morbidity Died after 8
months GI
bleeding
ycin Co-morbidity Alive Aneurysm
expansion and
grafting after 3
monthsinal a
e of a
arcilli
lavula
lus am
triaxo
triaxo
iprofl
azoli
triaxo
iprofl
triaxo
triaxo
copla
omo
otaxi
iprofl
triaxo
iprofl
triaxo
o-
rimox
triaxo
iprofl
triaxo
iprofl
comrate after long-term follow-up was 59% (13 of 22). The
issio
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Of seven patients who were event-free after one year, six
patients had infection caused by nontyphoid Salmonella.
Of the seven patients having a successful medical treatment,
the antibiotic regimen was intravenous ceftriaxone fol-
lowed by oral ciprofloxacin in four patients, intravenous
cefotaxime followed by ciprofloxacin in one, ciprofloxacin
alone in one and intravenous ceftriaxone followed by oral
co-trimoxazole in 1 (Tables I and II).
Salmonella infection. Of the 22 patients in this series,
11 patients (50%) had infection caused by nontyphoid
Salmonella and the impact of Salmonella infection on clin-
ical outcomes is shown in Table III. Of 11 patients with
Salmonella infection, eight patients had abdominal infec-
tion, while six of 11 patients with infection caused by
organisms other than Salmonella had abdominal infection.
Eight patients with Salmonella infection (73%) have lived
beyond 30 days and six (55%) were event-free after one
year. In contrast, of 11 patients with non-Salmonella
infections, four patients have lived beyond 30 days and
only one (9%) was event-free after one year. Thus, the
overall aneurysm-related mortality rate was 36% in Salmo-
nella infected patients and 82% in non-Salmonella infected
Fig. Infected aneurysm of the aorta and adjacent arteries
without undergoing aortic resection during the first adm
Table III. Salmonella infection and clinical outcomes in
infected aneurysm of the aorta and adjacent arteries
treated without undergoing aortic resection
Variables Salmonella Non-Salmonella
Abdominal infection 73% (8/11) 55% (6/11)
Event-free survival at one year 55% (6/11) 9% (1/11)
Aneurysm-related mortality 36% (4/11) 82% (9/11)patients.DISCUSSION
Infected aneurysm of the aorta and adjacent arteries is
historically a deadly disease with high mortality and mor-
bidity and the anatomic location of the aortic sepsis, the
virulence of the infecting organism, and the severity of
infection are the important factors affecting prognosis.1-19
The successful resolution of these uncommon but not rare
aortic lesions relates directly to early diagnosis, administra-
tion of specific systemic antibiotics, and timely surgical
intervention. The surgical intervention includes extensive
aortic resection and vascular reconstruction. Previous stud-
ies have focused mainly on the results of combined medical
and open surgical treatment,1-19 and there have been al-
most no hospital survivors if patients were treatedmedically
without undergoing aortic resection.11-13 In this current
series of 22 patients treated medically without undergoing
aortic resection, the prognosis was not uniformly fatal but
the results did not match our reported survival after open
surgical repair.16,17
Salmonella infection. In western countries, the most
common responsible organisms for infected aortic aneu-
rysms are Staphylococcus aureus and Streptococcus spe-
cies.1-10 In contrast, in Taiwan, nontyphoid Salmonella is
the most common pathogen.14-19 It has been reported that
aneurysms infected with Gram negative organisms exhibit a
greater tendency toward early rupture than those with gram
positive organisms and are thus associated with a higher
mortality.11 Delay in making the diagnosis adversely affects
the death rate. Treated with antibiotics alone, infected
aneurysms due to salmonella have been reported to be
almost uniformly fatal and until 1976, only four survivors
were known in the literature.10,21-23 Use of medical ther-
apy alone was also fatal in three patients described in a
rysm location and clinical outcome in 22 patients treated
n.: aneuprevious Taiwanese series of 16 patients with pathologically
JOURNAL OF VASCULAR SURGERY
January 200970 Hsu et aldocumented Salmonella aortitis.15 Although data from
previous studies are limited, the prognosis with medical
therapy alone is grim, even with use of third generation
cephalosporin.
However, the prognosis of infected aneurysm caused
by nontyphoid Salmonella has significantly improved in the
last two decades. In this current series, there were 11
patients with infected aortic aneurysms caused by nonty-
phoid Salmonella and the prognosis of infection caused by
nontyphoid Salmonella was not dismal. Furthermore, the
prognosis of infected aneurysms caused by nontyphoid
Salmonella was much better than that of non-Salmonella
infected cases with none of them being event-free beyond
one year. Therefore, it is recommended that patients with
infected aortic aneurysm caused by micro-organisms other
than nontyphoid Salmonella should undergo open sur-
gical repair regardless of the surgical risks. In contrast, in
Salmonella-infected patients who refuse operation because
of high surgical risks, we recommend the use of intravenous
ceftriaxone for four to six weeks followed by life-long oral
ciprofloxacin, as about half of them will survive after one
year. However, the emergence of ciprofloxacin resistance
could be a threat,24,25 and further studies are needed on the
choice of life-long oral antibiotic in ciprofloxacin-resistant
nontyphoid Salmonella infection.
Study limitation. The major limitations of this study
are a retrospective study design and a long time span.
Because of retrospective study design, there was no consis-
tent approach to these patients and the decision for open
surgical repair was also variable. However, this study is the
largest case series of infected aortic aneurysm treated med-
ically without undergoing aortic resection and provides
useful information in management of high-risk patients.
In conclusion, clinical results of medical treatment using
current antibiotics in patients with infected aortic aneurysm
are still poor. However, the prognosis is not dismal in nonty-
phoid Salmonella infected patients. In contrast, patients with
infection caused by micro-organisms other than nontyphoid
Salmonella should undergo early surgical repair.
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